S'abonner

Investigating the effect of enhanced cleaning and disinfection of shared medical equipment on health-care-associated infections in Australia (CLEEN): a stepped-wedge, cluster randomised, controlled trial - 28/11/24

Doi : 10.1016/S1473-3099(24)00399-2 
Katrina Browne, PhD a, Nicole M White, PhD b, Philip L Russo, ProfPhD a, e, g, Allen C Cheng, ProfPhD c, d, Andrew J Stewardson, PhD f, Georgia Matterson, BBiotech h, Peta E Tehan, PhD d, h, Kirsty Graham, BNurs j, Maham Amin, MHlthLdr j, Maria Northcote, ProfPhD i, Martin Kiernan, MClinRes k, Jennie King, PhD j, l, David Brain, PhD b, Brett G Mitchell, ProfPhD e, h, j, m,
a School of Nursing and Health, Avondale University, Wahroonga, NSW, Australia 
b Australian Centre for Health Services Innovation, School of Public Health and Social Work, Queensland University of Technology, Brisbane, QLD, Australia 
c Department of Infectious Diseases, Monash Health, Clayton, VIC, Australia 
d School of Clinical Sciences, Monash University, Clayton, VIC, Australia 
e School of Nursing and Midwifery, Monash University, Clayton, VIC, Australia 
f Department of Infectious Diseases, The Alfred and School of Translational Medicine, Monash University, Melbourne, VIC, Australia 
g Cabrini Health, Malevern, VIC, Australia 
h School of Nursing and Health, Avondale University, Cooranbong, NSW, Australia 
i Research Services, Avondale University, Cooranbong, NSW, Australia 
j Central Coast Local Health District, Gosford, NSW, Australia 
k Richard Wells Research Centre, University of West London, Brentford, UK 
l School of Nursing and Midwifery, University of Newcastle, Gosford, NSW, Australia 
m Hunter Medical Research Institute, New Lambton Heights, NSW, Australia 

* Correspondence to: Prof Brett G Mitchell, School of Nursing and Health, Avondale University, Cooranbong, NSW 2265, Australia School of Nursing and Health Avondale University Cooranbong NSW 2265 Australia

Summary

Background

There is a paucity of high-quality evidence based on clinical endpoints for routine cleaning of shared medical equipment. We assessed the effect of enhanced cleaning and disinfection of shared medical equipment on health-care-associated infections (HAIs) in hospitalised patients.

Methods

We conducted a stepped-wedge, cluster randomised, controlled trial in ten wards of a single hospital located on the central coast of New South Wales, Australia. Hospitals were eligible for inclusion if they were classified as public acute group A according to the Australian Institute of Health and Welfare, were located in New South Wales, had an intensive care unit, had a minimum of ten wards, and provided care for patients aged 18 years or older. Each cluster consisted of two randomly allocated wards (by use of simple randomisation), with a new cluster beginning the intervention every 6 weeks. Wards were informed of their allocation 2 weeks before commencement of intervention exposure, and the researcher collecting primary outcome data and audit data was masked to treatment sequence allocation. In the control phase, there was no change to environmental cleaning practices. In the intervention phase, a multimodal cleaning bundle included an additional 3 h per weekday for the dedicated cleaning and disinfection of shared medical equipment by 21 dedicated cleaning staff, with ongoing education, audit, and feedback. The primary outcome was the number of confirmed cases of HAI, as assessed by a fortnightly point prevalence survey and measured in all patients admitted to the wards during the study period. The completed trial is registered with Australia New Zealand Clinical Trials Registry (ACTRN12622001143718).

Findings

The hospital was recruited on July 31, 2022, and the study was conducted between March 20 and Nov 24, 2023. We assessed 220 hospitals for eligibility, of which five were invited to participate, and the first hospital to formally respond was enrolled. 5002 patients were included in the study (2524 [50·5%] women and 2478 [49·5%] men). In unadjusted results, 433 confirmed HAI cases occurred in 2497 patients (17·3%, 95% CI 15·9 to 18·8) in the control phase and 301 confirmed HAI cases occurred in 2508 patients (12·0%, 10·7 to 13·3) in the intervention phase. In adjusted results, there was a relative reduction of –34·5% (–50·3 to –17·5) in HAIs following the intervention (odds ratio 0·62, 95% CI 0·45 to 0·80; p=0·0006), corresponding to an absolute reduction equal to –5·2% (–8·2 to –2·3). No adverse effects were reported.

Interpretation

Improving the cleaning and disinfection of shared medical equipment significantly reduced HAIs, underscoring the crucial role of cleaning in improving patient outcomes. Findings emphasise the need for dedicated approaches for cleaning shared equipment.

Funding

National Health and Medical Research Council.

Le texte complet de cet article est disponible en PDF.

Plan


© 2024  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 24 - N° 12

P. 1347-1356 - décembre 2024 Retour au numéro
Article précédent Article précédent
  • Trends in infection incidence and antimicrobial resistance in the US Veterans Affairs Healthcare System: a nationwide retrospective cohort study (2007–22)
  • Thi Mui Pham, Yue Zhang, McKenna Nevers, Haojia Li, Karim Khader, Yonatan H Grad, Marc Lipsitch, Matthew Samore
| Article suivant Article suivant
  • Effectiveness of rVSV-ZEBOV vaccination during the 2018–20 Ebola virus disease epidemic in the Democratic Republic of the Congo: a retrospective test-negative study
  • Sophie Meakin, Justus Nsio, Anton Camacho, Richard Kitenge, Rebecca M Coulborn, Etienne Gignoux, John Johnson, Esther Sterk, Elisabeth Mukamba Musenga, Stephane Hans Bateyi Mustafa, Epicentre-MSF EVD Working Group, Flavio Finger, Steve Ahuka-Mundeke

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.